Group One Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34,000
| Closed | -$813K | – | 8860 |
|
|
2021
Q1 | $813K | Buy |
34,000
+22,500
| +196% | +$418K | ﹤0.01% | 3485 |
|
|
2020
Q4 | $168K | Sell |
11,500
-8,400
| -42% | -$111K | ﹤0.01% | 4196 |
|
|
2020
Q3 | $283K | Buy |
19,900
+9,300
| +88% | +$142K | ﹤0.01% | 3364 |
|
|
2020
Q2 | $156K | Sell |
10,600
-115,100
| -92% | -$1.17M | ﹤0.01% | 3582 |
|
|
2020
Q1 | $518K | Buy |
+125,700
| New | +$589K | ﹤0.01% | 2027 |
|
|
2017
Q3 | – | Sell |
-4,900
| Closed | -$58K | – | 5348 |
|
|
2017
Q2 | $58K | Hold |
4,900
| – | – | ﹤0.01% | 3434 |
|
|
2017
Q1 | $63K | Buy |
4,900
+4,500
| +1,125% | +$54.2K | ﹤0.01% | 3272 |
|
|
2016
Q4 | $5K | Hold |
400
| – | – | ﹤0.01% | 4120 |
|
|
2016
Q3 | $5K | Buy |
+400
| New | +$3.86K | ﹤0.01% | 4232 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$1K | – | 5276 |
|
|
2015
Q3 | $1K | Sell |
100
-7,000
| -99% | -$64.7K | ﹤0.01% | 4788 |
|
|
2015
Q2 | $64K | Hold |
7,100
| – | – | ﹤0.01% | 3387 |
|
|
2015
Q1 | $92K | Buy |
+7,100
| New | +$92.8K | ﹤0.01% | 2957 |
|
|
2014
Q4 | – | Sell |
-2,400
| Closed | -$22K | – | 5430 |
|
|
2014
Q3 | $22K | Sell |
2,400
-700
| -23% | -$7.53K | ﹤0.01% | 4078 |
|
|
2014
Q2 | $42K | Buy |
3,100
+900
| +41% | +$9.39K | ﹤0.01% | 3660 |
|
|
2014
Q1 | $22K | Buy |
2,200
+1,500
| +214% | +$18.6K | ﹤0.01% | 4189 |
|
|
2013
Q4 | $9K | Buy |
700
+200
| +40% | +$2.43K | ﹤0.01% | 4643 |
|
|
2013
Q3 | $6K | Sell |
500
-2,400
| -83% | -$25.7K | ﹤0.01% | 4701 |
|
|
2013
Q2 | $30K | Buy |
+2,900
| New | +$40K | ﹤0.01% | 3835 |
|
Group One Trading's GNMK Position: Q2 2021 in Review
Group One Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,288 shares — an estimated $31K sold.
Group One Trading first reported a position in GNMK in Q2 2013 and held it in 8 quarters. The position peaked at $307K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Group One Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Group One Trading sold 1,288 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $31K.
- Group One Trading first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 8 quarters.
- Group One Trading's GenMark Diagnostics, Inc position peaked at $307K in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.